Peterson Amy C.
SEC CIK 1682735 · EDGAR
BoughtSold
Most active insiders at EXEL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Aftab Dana | EVP, Research, Development | — | $7.70M |
| 2 | Haley Patrick J. | EVP, Commercial | — | $7.60M |
| 3 | Smith Julie | Dir | — | $4.69M |
| 4 | WYSZOMIERSKI JACK L | Dir | — | $4.58M |
| 5 | Senner Christopher J. | EVP, CFO | — | $4.56M |
| 6 | PAPADOPOULOS STELIOS | Dir | — | $4.36M |
| 7 | POSTE GEORGE | Dir | — | $2.74M |
| 8 | Beckerle Mary C | Dir | — | $1.93M |
| 9 | Oliver Bob | Dir | — | $1.33M |
| 10 | Caligan Partners LP | Dir, See Remarks | $1.19M | — |
Peterson Amy C. made no open-market trades at EXEL in the last 12 months.
Transactions 12
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-05-16 | 2025-05-16 | EXEL | EXELIXIS, INC. | Peterson Amy C. | CMO, EVP Prod Dev, Med Aff | S - Sale+OE | $45.47 | -72.8K | 465.4K | -14% | -$3.31M |
| D | 2025-05-16 | 2025-05-15 | EXEL | EXELIXIS, INC. | Peterson Amy C. | CMO, EVP Prod Dev, Med Aff | F - Tax | $44.65 | -8,303 | 498.2K | -2% | -$370.7K |
| D | 2025-05-16 | 2025-05-16 | EXEL | EXELIXIS, INC. | Peterson Amy C. | CMO, EVP Prod Dev, Med Aff | M - OptEx | $21.75 | +40.0K | 538.2K | +8% | +$870.0K |
| 2025-03-31 | 2025-03-31 | EXEL | EXELIXIS, INC. | Peterson Amy C. | CMO, EVP Prod Dev, Med Aff | A - Grant | $0.00 | +159.4K | 506.5K | +46% | $0 | |
| 2025-02-28 | 2025-02-26 | EXEL | EXELIXIS, INC. | Peterson Amy C. | CMO, EVP Prod Dev, Med Aff | A - Grant | $0.00 | +52.2K | 347.1K | +18% | $0 | |
| 2024-11-19 | 2024-11-15 | EXEL | EXELIXIS, INC. | Peterson Amy C. | CMO, EVP Prod Dev, Med Aff | F - Tax | $35.05 | -27.2K | 294.9K | -8% | -$954.2K | |
| 2024-02-27 | 2024-02-23 | EXEL | EXELIXIS, INC. | Peterson Amy C. | CMO, EVP Prod Dev, Med Aff | A - Grant | $0.00 | +82.1K | 322.1K | +34% | $0 | |
| D | 2023-08-25 | 2023-08-24 | EXEL | EXELIXIS, INC. | Peterson Amy C. | CMO, EVP Prod Dev, Med Aff | A - Grant | $0.00 | +240.0K | 240.0K | New | $0 |
| 2023-03-20 | 2023-03-16 | CTMX | CytomX Therapeutics, Inc. | Peterson Amy C. | EVP, Chief Development Off | S - Sale | $1.98 | -4,257 | 58.4K | -7% | -$8,429 | |
| 2022-07-21 | 2022-07-19 | CTMX | CytomX Therapeutics, Inc. | Peterson Amy C. | EVP, Chief Development Off | A - Grant | $0.00 | +20.0K | 70.2K | +40% | $0 | |
| 2022-07-21 | 2022-07-20 | CTMX | CytomX Therapeutics, Inc. | Peterson Amy C. | EVP, Chief Development Off | S - Sale | $1.42 | -7,463 | 62.7K | -11% | -$10.6K | |
| D | 2022-02-04 | 2022-02-02 | CTMX | CytomX Therapeutics, Inc. | Peterson Amy C. | EVP, Chief Development Off | A - Grant | $0.00 | +40.0K | 46.4K | +623% | $0 |
Purchase Sale Sale after option exercise All abbreviations